Most AMDM-related NPR2 mutations are hypothesized to cause disease by impairing trafficking to the plasma membrane, altering CNP ligand binding affinity, or inhibiting the activity of NPR-B. This evidence concerns the gene CNP and acromesomelic dysplasia 1, Maroteaux type.